Moneycontrol
HomeNewsBusinessReal EstateOver 15 Noida builders get 6-month extension up to December 2021 to complete pending projects
Trending Topics

Over 15 Noida builders get 6-month extension up to December 2021 to complete pending projects

The Noida Authority board also gave its nod to the decision of not imposing penalty on land allottees who could not get their documents executed during the lockdown period

August 19, 2020 / 14:41 IST
Story continues below Advertisement

In the wake of the COVID-19 pandemic, Noida Authority has extended the deadline for over 15 builders to complete the pending projects by December 31, 2021, under its 'zero period' policy, an official statement said.

The board also gave its nod to the decision of not imposing a penalty on land allottees who could not get their documents executed or take over possession during the lockdown period.

Story continues below Advertisement

"The developers who have given written assurance to complete their pending projects by December 31, 2021, have been given an extension till December 31, 2021, from June 30, 2021, as part of the zero period policy. Sixteen (land) allottees have been issued letters for giving written assurance regarding completing the incomplete projects by December 31, 2021," an official release said.

These builders had earlier assured delivery of homes by the end of June 2021.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show